Sprinklr Announces Third Quarter Fiscal 2022 Results

Go back to Sprinklr Announces Third Quarter Fiscal 2022 Results
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 5.62 +0.03 (0.54%)
Previous Close $5.59    52 Week High $1.44 
Open $5.52    52 Week Low $0.06 
Day High $5.65    P/E N/A 
Day Low $5.45    EPS $-1.24 
Volume 2,833,698